-
153 Therapeutics is a pre-clinical stage company spun out of UCSF and developing small-molecule therapeutics for Parkinson's Disease (PD) and other CNS disorders. Our core science is a based on target ... -
Aanastra Inc is a start-up biopharmaceutical company focused on treating cancer with novel RNA therapeutics using its tissue-targeting peptide platform to target and rescue undruggable and mutated Tum ... -
ABYOLO: Biosimilars for Everyone, Everywhere ABYOLO is a global biosimilar company committed to making biological medicines accessible and affordable to everyone, everywhere. Our mission is to bridge ... -
As the newest iterations of commercial and open-source molecular modeling tools and large-language models lower the barriers for implementing AI applications at biotechs, the challenge for management ...
-
Drug-target binding affinity is pivotal in determining therapeutic efficacy. AKSO Bio's proprietary DEEP protein engineering platform, enhanced with AI, not only invents biologic therapeutics with ult ... -
Alphyn is developing breakthrough therapies for the most challenging, severe, and common skin diseases using its proprietary Zabalafin (AB-101) Platform for Multi-Target Therapeutics™. The Company’s l ... -
Amaro Therapeutics is an early-stage therapeutic platform company focused on the activation of ubiquitously expressed chemosensory receptors (TAS2R), as therapeutic targets, for the treatment of human ... -
Amyloid Solution Inc. is a pioneering biotech company at the forefront of discovering disease-modifying targets and developing novel drug candidates, including small molecules and other innovative mod ...
-
Arialys is a private therapeutics company developing precision medicines for autoimmune neuropsychiatric disease. The field of autoimmune neuropsychiatry is rapidly evolving beyond well characterized ... -
Atheon Bio is revolutionizing immune-oncology by pushing the limits of what was once thought impossible, bringing the treatments to patients worldwide. We introduce an innovative therapeutic strategy ... -
Aureka Biotechnologies is a premier biotech startup committed to democratizing the pharmaceutical industry to defeat disease. Empowered by our integrated digital biology and AI solutions, Aureka enabl ... -
Avexo Pharmaceuticals is transforming the field of metabolomics through advanced experimental techniques to identify key metabolites that drive maternal immunity. Our groundbreaking research has uncov ... -
Avstera Therapeutics is an oncology-focused biotech company headquartered in the Philadelphia area dedicated to address the large disease burden and significant unmet need of cancer patients. With a f ... -
BIO has collaborated with a set of programs focused on entrepreneur development to curate an afternoon of seed-stage company pitches from promising new companies ready to pursue investment or partneri ...
-
BIO has collaborated with a set of programs focused on entrepreneur development to curate an afternoon of seed-stage company pitches from promising new companies ready to pursue investment or partneri ...
-
BioSuperior has created a unique lipid nanoparticle (LNP) based on a naturally occurring biomaterial that is essential for breathing. Our LNP will be used to deliver disease-modifying treatments conta ... -
NEW TREATMENT FOR ALZHEIMER'S DISEASE AND LONG COVID DEMENTIA -
Cenos Therapeutics is pioneering the future of neurological health through innovative RNA therapeutics. The company’s proprietary BBB-crossing conjugate RNA platform enables deep brain delivery via su ... -
Join us for a Closing Networking Happy Hour.
-
CNCure Co., Ltd. is a pioneering biotech company, founded in 2019 and funded with $10M USD to date, at the forefront of developing revolutionary bacteria-based cancer immunotherapy (BCIT) and radiopha ... -
Coastar Therapeutics has pioneered a bioengineered cell membrane delivery platform facilitating gene delivery and editing within the body. Serving as a Trojan horse, this platform ingeniously conceals ... -
Our mission is to restore volentary bowel and bladder function to the 2million patients confined to wheelchairs and who suffer from other neurological disease.
-
At El Capitan Biosciences (ECB), our mission is to harness advanced machine learning algorithms to discover novel clinically-significant biomarkers in stool samples to zero-out the incident of CRC. By ... -
Advances in neurodegenerative science have pointed to new paths in the development of medicines that have the potential to dramatically improve patient quality of life. These advances are contributing ...
-
Asish is the Vice President, Venture Investments at Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and is based at the Johnson & Johnson Innovation Center in San Francisco, California. Asish focuses ...
-
Phase 2 private biotech developing neoantigen targeted personalized therapeutic cancer vaccines (PTCVs) based on proprietary DNA platform. Compared with mRNA-based cancer vaccines currently under deve ...
-
Helex is extending the frontier of breakthrough genetic medicines to meet the significant underserved medical needs of patients with chronic kidney diseases, which affect 1 in 7 individuals globally. ... -
HepaTx is focused on applying regenerative medicine to liver disease. Our lead product, Hx-001, addresses the large and completely unmet need in late stage liver disease. This single product is promis ... -
ImBiome is a Live Bio-therapeutic Products (LBP) platform company with first-in-class antibiotic replacement drug for GI infectious diseases (gastroenteritis). Our products are enabled by a pioneering ... -
Inimmune designs and develops novel immunotherapeutic compounds and delivery systems that target relevant pathways of the innate immune system to drive disease-modifying responses in areas of high unm ... -
InnoPath Therapeutics is developing a platform of transformational topical therapeutics to treat the tens of millions of people who get non-melanoma skin cancer and pre-cancers each year. In contrast ... -
KAHR is a clinical stage company developing novel immune-recruiting therapies that treat cancer at the source by unleashing the synergistic power of the body’s innate and adaptive immune responses. Th ... -
.jpg)
Kuda Therapeutics is a Salt Lake City based oncology company focused on the development of first-in-class therapeutics for cancer. Kuda is funded entirely by non-dilutive government grants and retains ... -
Lmito is an innovation-driven biotechnology company dedicated to the development of novel and effective therapies for autoimmune diseases and fibrosis, through an emerging concept of ‘metabolic reprog ... -
Lunar Biosciences, a biotech startup headquartered in Pleasanton, California, is revolutionizing the field of proteomics with its innovative technology. Our focus is on developing a groundbreaking pro ... -
At Macro Biologics, Inc, we design, patent, and produce large molecule biologics for innovative products across multiple industries – from healthcare to food & water to packaging. Amicidins, our first ... -
Filament Health (Filament) and Jaguar Health (Jaguar) joined forces in early 2023 to create Magdalena Biosciences, Inc. in order to leverage their mutual expertise in botanical drug development, plant ... -
While the rate of IPOs this year is slightly increased versus 2023, the market is still much less active since 2021 and hoping the Q3 interest rate cut of 0.5% sparks additional investor support. This ...
-
MicuRx is a multi-asset clinical stage company biotech company focusing on improving the quality of life for patients with rare chronic pulmonary diseases. The lead asset MRX-5 has completed phase 1 f ... -
.png)
miRecule Inc. is a biotechnology company which develops highly tissue-targeted RNA therapeutics for neuromuscular diseases and oncology indications. Their proprietary DREAmiR™ platform identifies gene ... -
APAC markets are among the largest and fastest growing in the world, with a legacy of successful international collaborations within drug development and direct investment in biotechs. However, post-p ...
-
A female-founded and led, San Francisco based biotech company, Nalu Bio is committed to transforming health and wellness to enhance quality of life and address chronic health issues. Our proprietary A ... -
Nine Square is developing novel treatments for neurodegenerative and age-related diseases by correcting autophagy dysfunction. Our programs are directed to high value, genetically validated targets an ... -
NovAb is developing a new class of antibodies, variable lymphocyte receptors (“VLRs”), discovered by our founding scientist, Dr. Max Cooper (Emory). VLRs are the immune receptors of jawless vertebrate ... -
Although world of cell & gene therapy, RNA and direct DNA therapies have seen lot of advancement, there has no advancement in manufacturing plasmid DNA for the last 50 years. Today's plasmid DNA indus ... -
Our company NUP-CTx Inc. is a little team of highly qualified scientists (biologists, physicians, biochemists). We are pioneering the next generation of cancer treatment in chemotherapy. In a nutshell ... -
OCMS technology screens millions of recombinant antibodies in mammalian cells for expression and antigen binding. OCMS can screen any antibody format (IgG, scFv, VHH), completing the full library anal ... -
OncoNano is a clinical-stage oncology company working to transform cancer therapeutics with its proprietary nanotechnology platform. OncoNano's ON-BOARD™ platform exploits the highly acidic tumor micr ... -
Ordaos is creating the next generation of more effective cancer and anti-viral therapeutics 30x faster than has ever been possible with its generative AI mini-protein design engine. Ordaos designs min ... -
Osmol is a clinical stage biopharma company developing a first-in-class preventative treatment (OSM-0205) for chemotherapy-induced peripheral neuropathy (CIPN). CIPN is a significant unmet need associ ... -
Owl Therapeutics – 1st FDA-Approved Drug for TBI - UNLOCKING WISDOM for BRAIN HEALTH Owl Therapeutics (“Owl”) is a clinical-stage biopharmaceutical company ready for investment in Phase 2 trials of de ... -
)
Pacylex Pharmaceuticals is the world leader in the clinical development of NMT inhibition therapy for cancer with multiple Phase 2a programs underway. Myristoylation is a post-translational modificati ... -
PartitionBio is a start-up R&D company that is active in the biotechnology & pharma sectors. The company has been operating since 2022 and is incorporated as a private limited company in the UK. Parti ...
-
PhenoTarget is developing first- and best-in-class small molecule therapeutics for fibrotic diseases including IPF, heart failure (HFpEF), and ADPKD. These compounds inhibit YAP nuclear localization a ... -
Phinomics, a Stanford spin-off from Andrew Fire's Nobel Prize-winning laboratory (2006), was established by a renowned team specializing in Genomics and Biophysics. Phinomics’ innovative and patented ... -
With the first pricing negotiation results of the Inflation Reduction Act now public, analysts will be diagnosing trends for commercial companies and the implications for their pipelines. Those pipeli ...
-
Prazer Therapeutics is a pioneering biotechnology company focused on the development of innovative therapies targeting previously untreatable diseases. Utilizing its proprietary SPiDEM™ (Selective Pro ... -
With oncology continuing to bear ripe opportunities for investors, new modalities such as antibody-drug conjugates (ADCs) and radiopharmaceuticals are garnering significant interest. These approaches ...
-
PTM Therapeutics was founded in 2020 based on the realization that post-translational modifications create highly specific disease targets for therapeutic antibodies. Our oncology program utilizes an ... -
Rakuten Medical, Inc. is a global biotechnology company founded in 2010, dedicated to developing and commercializing precision cell-targeting therapies through our proprietary Alluminox™ platform. Our ... -
Rejuvenation Technologies is a late-preclinical biotech therapeutics company addressing telomere shortening in age-related diseases such as pulmonary fibrosis, liver cirrhosis, and cytopenia using an ... -
Repoxegen is developing a new, patented treatment for retinal- and neuro- degeneration. Our oral small molecule drug targets an enzyme that seems to be a central switch in shifting from chronic destru ... -
Resolute Science is a preclinical-stage biotechnology company developing a novel class of pan-cancer therapeutics for the treatment of aggressive and hard-to-treat solid tumors. By leveraging its prop ... -
We are on a mission to stabilize and regenerate muscle using novel, first-in-class drugs. Muscle wasting diseases, such as muscular dystrophy, cachexia, and sarcopenia, create a significant burden, af ... -
Seraxis is bringing transformative cures to the millions of T1D and insulin-requiring T2D patients who all struggle with the management and life-threatening complications of their disorder. Seraxis’ i ... -
SLAM Bio is an oncology biotech company developing a platform of first-in-class antibodies and bispecifics against signaling lymphocytic activation molecule (SLAM) protein family. This is an intriguin ... -
In 2020, SONIRE was found and began developing a novel ultrasound-guided high-intensity focused ultrasound (HIFU) therapy system. HIFU therapy is a treatment method that focuses ultrasound waves emitt ... -
SPOC Proteomics Inc. is pioneering breakthroughs in proteomics with its foundational Sensor-Integrated Proteome on Chip (SPOC) technology. SPOC solves two key challenges (i) producing thousands of ful ... -
In a highly competitive landscape, closing your next financing round or inking a partnership with big pharma requires that you effectively capture attention then clearly demonstrate your value proposi ...
-
Sustained Therapeutics is a clinical stage company developing a drug delivery platform initially focused on non-opioid pain medication but extendable to other APIs including significant oncology indic ... -
.png)
Thirona Bio is developing a precision targeted drug platform to treat skin and lung fibrosis as well as certain cancers. The Company's therapies are organ-selective and locally acting inhibitors of TG ... -
Tiba is a preclinical stage MIT venture developing RNA medicines based on a novel biodegradable nanoparticle delivery technology. Our proprietary delivery system is based on ionizable aminoalkyl branc ... -
TiCARos is a clinical-stage biopharmaceutical company focused on transforming cancer treatment through CAR-T cell therapies. Our innovative approach leverages three proprietary technologies—CLIP (CLam ... -
TrAMPoline Pharma was founded with a vision to support the next generation of cellular immunotherapies to treat solid tumors. We are developing vectors encoding proprietary co-receptor and signaling p ... -
The latest HSBC Venture Healthcare report shows increased levels of investment in 2024 with Seed and Series A total investment doubling and investment in preclinical deals already surpassing 2023. The ...
-
VerImmune is developing a groundbreaking "virus-inspired"particle (ViP) non-viral delivery platform that self-assembles, offering transformative potential for therapeutic applications. Our lead progra ... -
Developing the next generation of antibody therapies, Vicero uses our proprietary VINCOBODY technology to build bi- and multi-specific antibodies and antibody drug conjugates with differentiated size, ... -
Vivodyne is a biotechnology company that accelerates the development of more effective medicines by testing on thousands of lifelike, lab-grown human organ tissues at a time. Robots are used to grow a ... -
Please join to learn the experienced perspective of Sharon Chan, PhD, VP Johnson & Johnson Innovation - JLABS Asia Pacific, for her views on innovation opportunities in the APAC region. As VP JLABS As ...
-
)
Ziphius is a preclinical biotech company specializing in vaccines and therapeutic drugs for infectious diseases, protein replacement therapies, and oncology. Founded in 2019, Ziphius has been advancin ...
OCTOBER 15-16, 2024 | Fairmont San Francisco, CA
OCTOBER 15-16, 2024 | Fairmont San Francisco, CA
2024 Program
.jpeg)
.jpg)
.png)
.jpg)
.jpg)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}